Actinomycin D in malignant Kaposi's sarcoma.
D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy*; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use*; D003875:Drug Eruptions; D005260:Female; D005534:Foot Diseases / Q000188:drug therapy; D006225:Hand; D006801:Humans; D008198:Lymph Nodes; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013280:Stomatitis / Q000139:chemically induced; D013848:Thigh; D014228:Triaziquone / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced
D003609:Dactinomycin; D014228:Triaziquone